LifeStance Health (LFST) Net Income towards Common Stockholders (2020 - 2026)

LifeStance Health has disclosed Net Income towards Common Stockholders across 7 years of filings, most recently posting $14.2 million for Q1 2026.

• In Q1 2026, Net Income towards Common Stockholders rose 1908.89% year-over-year to $14.2 million; the TTM figure through Mar 2026 stood at $23.2 million (up 165.09% YoY), while the FY2025 annual figure was $9.7 million, up 116.82% from the prior year.
• Net Income towards Common Stockholders improved to $14.2 million in Q1 2026, from $11.7 million in the prior quarter.
• Over the last five years, Net Income towards Common Stockholders for LFST reached as high as $14.2 million in Q1 2026 and fell as low as -$68.7 million in Q2 2022.
• The 5-year median for Net Income towards Common Stockholders is -$23.3 million (2024), against an average of -$25.6 million.
• Annual changes were most pronounced in 2023 — Net Income towards Common Stockholders sank 62.69% — and 2026, when it soared 1908.89%.
• A 5-year view of Net Income towards Common Stockholders shows it stood at -$46.7 million in 2022, then increased by 3.64% to -$45.0 million in 2023, then soared by 84.18% to -$7.1 million in 2024, then surged by 264.06% to $11.7 million in 2025, then gained by 22.07% to $14.2 million in 2026.
• According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered $14.2 million, $11.7 million, and $1.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.